- Industry Type
- Facilities & Equipment
RCC is committed to providing pharmaceutical and biotechnology company’s solutions for the discovery and development of new medicines.
Our aim at RCC is to offer a smooth and seamless process as your trusted partner who can serve as an extension of your dedicated team. RCC offers a one stop solution for your safety evaluation needs for IND/CTA and NDA enabling studies through the drug development process. RCC has clientele which includes global pharma clients to emerging biotech across ASEAN countries, Europe and USA.
Our brilliant team of scientists can help in the development of an individual molecule to support an entire portfolio ranging across the drug development cycle. With a unique range of quality services and best-in- class expertise, we help our clients successfully to initiate and complete their IND enabling program on time and within budget. We can help the clients to customize each exploratory IND enabling program based upon the type of drug, its intended route of administration and its clinical indication.